Company intelligence / Profile preview

Nutrium

Lisbon, Lisbon, Portugal

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Nutrium's platform delivers measurable clinical and financial outcomes for corporate partners, such as an average 5% reduction in member weight over four months, reduced need for prescription medication, and increased employee productivity. Adherence and retention rates are higher compared to pharmaceutical interventions.

Therapeutic areas: OtherEndocrinologyMetabolic Disorders
Modalities: Non-pharmacological therapyDigital health platformTelehealth
Industry: Digital Health Medical Devices

Partnerships

WellhubAdidasVodafoneTalkspaceCorporate health plans and consulting firms

Beyond the preview

Go deeper on Nutrium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrium.

Explore the full profile